Micheál Martin (Cork South Central, Fianna Fail) | Oireachtas source

We have known about this drug for quite some time. Over the past number of years, it has been going through the various regulatory systems and clinical trials. It could have a significant impact on inpatient attendances, etc.

Has the Minister for Health or anyone in the Government met the drug company, Vertex, or has there been any proactive engagement with a view to ensuring the availability of this drug in the marketplace? Can the Taoiseach outline to the House the steps that have been taken by the Government to ensure the availability of this drug to those with this condition?

See this speech in context